Human Milk Oligosaccharides (HMO) - Global Strategic Business Report

The global market for Human Milk Oligosaccharides (HMO) was estimated at US$122.5 Million in 2025 and is projected to reach US$299.8 Million by 2032, growing at a CAGR of 13.6% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Human Milk Oligosaccharides (HMO) Market - Key Trends and Drivers Summarized

Why Are Human Milk Oligosaccharides (HMO) Essential for Infant Nutrition?

Human Milk Oligosaccharides (HMOs) are complex carbohydrates found in human breast milk that play a crucial role in infant health and development. HMOs serve as prebiotics, promoting the growth of beneficial gut bacteria, which supports the infant's immune system and overall digestive health. Although HMOs are not digestible by infants, they provide a range of benefits, including protecting against pathogens and reducing the risk of infections. In recent years, the infant formula industry has recognized the importance of HMOs in mimicking the benefits of breast milk, leading to the incorporation of synthetic HMOs in formula products to support the growth and development of formula-fed infants.

How Are Technological Advancements Shaping the Human Milk Oligosaccharides Market?

The market for Human Milk Oligosaccharides has grown significantly due to advancements in biotechnology that allow for the large-scale production of synthetic HMOs. Using microbial fermentation techniques, manufacturers can produce HMOs identical to those found in human milk, making it possible to add these compounds to infant formula. This development has been transformative, as it enables formula-fed infants to receive some of the immune-boosting and digestive benefits previously only available through breastfeeding. Furthermore, ongoing research into the diverse types of HMOs - over 200 variations - has opened new opportunities for creating targeted infant nutrition products that support specific health outcomes, such as improved gut health or enhanced immune function.

How Do Market Segments Define the Growth of the Human Milk Oligosaccharides Market?

Types of HMOs include 2’-Fucosyllactose (2’-FL), Lacto-N-neotetraose (LNnT), and other complex oligosaccharides, with 2’-FL being the most commonly used in infant formula due to its proven health benefits and ease of production. Applications of HMOs are primarily found in infant nutrition, but they are also being explored for adult nutrition and dietary supplements due to their potential benefits in gut health and immune function. Distribution channels include supermarkets, pharmacies, and online platforms, with online sales seeing rapid growth as e-commerce expands in the infant nutrition sector. The market is also expanding geographically, with North America and Europe leading, while Asia-Pacific is experiencing significant growth due to rising awareness of infant nutrition.

What Factors Are Driving the Growth in the Human Milk Oligosaccharides Market?

The growth in the Human Milk Oligosaccharides market is driven by several factors, including increasing awareness of the health benefits of HMOs, advancements in biotechnology for large-scale production, and rising demand for premium infant nutrition products. As parents become more informed about the importance of gut health and immune support in early development, demand for HMO-enriched formula has surged. Technological innovations in microbial fermentation have made the production of HMOs more cost-effective, allowing manufacturers to include these compounds in a wider range of products. Additionally, the growing middle-class population in emerging markets, coupled with rising disposable income, has boosted demand for high-quality, science-backed infant nutrition products, further fueling the expansion of the HMO market.

Report Scope

The report analyzes the Human Milk Oligosaccharides (HMO) market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Application (Infant Formula, Functional Food & Beverage, Food Supplements, Other Applications).
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Infant Formula segment, which is expected to reach US$239.5 Million by 2032 with a CAGR of 13.4%. The Functional Food & Beverage segment is also set to grow at 16.9% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $37.9 Million in 2025, and China, forecasted to grow at an impressive 18.3% CAGR to reach $75.8 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Human Milk Oligosaccharides (HMO) Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Human Milk Oligosaccharides (HMO) Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Human Milk Oligosaccharides (HMO) Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Basf SE, Dextra Laboratories Limited, DuPont Nutrition & Health, Elicityl SA, Glycom A/S and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Human Milk Oligosaccharides (HMO) market report include:

• Basf SE
• Dextra Laboratories Limited
• DuPont Nutrition & Health
• Elicityl SA
• Glycom A/S
• Glycosyn LLC
• Inbiose
• Jennewein Biotechnologie GmbH
• Medolac Laboratories
• Nestlé Health Science
• ZuChem, Inc.

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 13 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.